More recently Conway et al. (analysis of 935 CpG sites in 517 breast tumours from the Carolina Breast Cancer Study) identified breast cancer DNA methylation to be associated with hormone receptor status, subtype and TP53 mutation status [237]. This evidence concerns the gene NR4A1 and breast cancer.